Hoffman William's Form 4 filing
Inari Medical, Inc. (NARI) · filed Nov 16, 2022
- Accession no.
- 0001127602-22-025857
- Filed
- Nov 16, 2022
- Trade date
- Nov 15, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 14 non-derivative transactions and 0 derivative transactions. Open-market sales total $4.49M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hoffman WilliamCIK 0001304099 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 15, 2022 | Common Stock | SSaleDisposed | −2,928 | $79.67 | −$233,273.76 | 289,553 | Direct | |
| Nov 15, 2022 | Common Stock | SSaleDisposed | −6,000 | $80.64 | −$483,840 | 283,553 | Direct | |
| Nov 15, 2022 | Common Stock | SSaleDisposed | −15,401 | $81.54 | −$1,255,797.54 | 268,152 | Direct | |
| Nov 15, 2022 | Common Stock | SSaleDisposed | −6,200 | $82.78 | −$513,236 | 261,952 | Direct | |
| Nov 15, 2022 | Common Stock | SSaleDisposed | −4,471 | $83.28 | −$372,344.88 | 257,481 | Direct | |
| Nov 15, 2022 | Common Stock | SSaleDisposed | −1,600 | $79.84 | −$127,744 | 255,881 | Direct | |
| Nov 15, 2022 | Common Stock | SSaleDisposed | −2,673 | $80.79 | −$215,951.67 | 253,208 | Direct | |
| Nov 15, 2022 | Common Stock | SSaleDisposed | −6,380 | $81.58 | −$520,480.4 | 246,828 | Direct | |
| Nov 15, 2022 | Common Stock | SSaleDisposed | −3,090 | $82.90 | −$256,161 | 243,738 | Direct | |
| Nov 15, 2022 | Common Stock | SSaleDisposed | −1,257 | $83.35 | −$104,770.95 | 242,481 | Direct | |
| Nov 15, 2022 | Common Stock | SSaleDisposed | −600 | $79.90 | −$47,940 | 241,881 | Direct | |
| Nov 15, 2022 | Common Stock | SSaleDisposed | −2,120 | $81.22 | −$172,186.4 | 239,761 | Direct | |
| Nov 15, 2022 | Common Stock | SSaleDisposed | −1,013 | $81.90 | −$82,964.7 | 238,748 | Direct | |
| Nov 15, 2022 | Common Stock | SSaleDisposed | −1,267 | $83.09 | −$105,275.03 | 237,481 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.